key: cord-0912953-96zknxkl authors: Tung, H.Y. Lim; Limtung, Pierre title: Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 date: 2020-08-15 journal: Biochem Biophys Res Commun DOI: 10.1016/j.bbrc.2020.08.024 sha: 469c0fc711383c75cb6146688822b87a30bd1b67 doc_id: 912953 cord_uid: 96zknxkl SARS-CoV-2 is the etiologic agent of COVID-19. There is currently no effective means of preventing infections by SARS-CoV-2, except through restriction of population movement and contact. An understanding of the origin, evolution and biochemistry (molecular biology) of SARS-CoV-2 is a prerequisite to its control. Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein isolated from various populations and locations, are described. Mutations occurred in the phosphorylation sites, all located within a stretch which forms a phosphorylation dependent interaction site, including C-TAK1 phosphorylation sites for 14-3-3. The consequences of these mutations are discussed and a structure-based model for the role of protein 14-3-3 in the sequestration and inhibition of SARS-CoV-2 nucleocapsid protein's function is presented. It is proposed that the phosphorylation of SARS-CoV-2 nucleocapsid protein and its sequestration by Protein 14-3-3 is a cellular response mechanism for the control and inhibition of the replication, transcription and packaging of the SARS-CoV-2 genome. SARS-CoV-2 is the etiologic agent of COVID-19. There is currently no effective means of preventing infections by SARS-CoV-2, except through restriction of population movement and contact. An understanding of the origin, evolution and biochemistry (molecular biology) of SARS-CoV-2 is a prerequisite to its control. Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein isolated from various populations and locations, are described. Mutations occurred in the phosphorylation sites, all located within a stretch which forms a phosphorylation dependent interaction site, including C-TAK1 phosphorylation sites for 14-3-3. The consequences of these mutations are discussed and a structure-based model for the role of SARS-CoV-2 is the etiologic agent of COVID-19 which is now considered a pandemic [1] [2] [3] [4] . Currently, the only effective means of avoiding morbidity due to infections by SARS-CoV-2 is through population control and contact restriction which appear to be quite effective in some parts of the world and not others. However, the number of deaths in various populations and regions of the world are not uniform [5, 6] . Although the medical infrastructure and response strategy and protocol play an important role in mitigating illness and death as a result of SARS-CoV-2 infection, the possibility that variability in the number of deaths following SARS-CoV-2 infections may be due to SARS-CoV-2 mutations cannot be ruled out. Several reports have documented mutations in several SARS-CoV-2 encoded proteins, in particular the Spike protein [7] which determines the infectivity of SARS-CoV-2 by binding to ACE2 [8, 9] . Other reports have described mutations in other proteins encoded by SARS-CoV-2, including the nucleocapsid protein [10] [11] [12] [13] [14] . SARS-CoV-2 nucleocapsid protein has an essential role in the replication, transcription and assembly of SARS-CoV-2 genome [15, 16] . There is also interest in developing drugs and vaccines that target the SARS-CoV-2 nucleocapsid protein [17, 18] which has also been shown to control the cell cycle of the host cell [19, 20] . The cell cycle control is regulated in large part by protein phosphorylation and dephosphorylation mechanisms involving a large number of protein kinases and protein phosphatases [21] [22] [23] [24] [25] . Development of drugs and vaccines that target SARS-CoV-2 nucleocapsid protein must take into account mutations in SARS-CoV-2 nucleocapsid protein that occur strains/sub-strains isolated in various populations and locations, and their functional significance. Here, we describe mutations of the phosphorylation sites of SARS-CoV-2 nucleocapsid protein that were isolated from several populations and locations. We identify the binding of the phosphorylation rich region of SARS-CoV-2 nucleocapsid protein to protein 14-3-3, an important signaling molecule that controls the cell cycle, cell survival and cell death [26] [27] [28] [29] [30] . We present a structure-based model of phosphorylation dependent binding and sequestration of SARS-CoV-2 nucleocapsid protein by protein 14-3-3. The consequences of these mutations are also discussed. and Asparagine respectively. Serine 186 is a phosphorylation site for CKI which is involved in the control a wide variety of cellular processes, including the control of the cell cycle [40] [41] [42] . Serine 197 is a phosphorylation site for Aurora A and B kinases which are involved in the control of the cell cycle and proper chromosome segregation [43] [44] [45] . Next to serine 197, is threonine 198 which is a phosphorylation site for proline directed protein kinases, including Cdk1 and GSK-3 [46] [47] [48] [49] [50] [51] [52] [53] . Serine 202 is a phosphorylation site for GSK-3 which is involved in a wide variety of cellular processes including, the control of the cell cycle [48] [49] [50] [51] . Figures 3 and 4) . Interestingly, Figures 3 and 4 shows that only the monomeric SARS-CoV-2 nucleocapsid protein can form a complex with protein 14-3-3, indicating that protein 14-3-3 acts to prevent the dimerization of SARS-COV-2 Nucleocapsid protein. The sequences of several SARS-CoV-2 strains have been determined [1] [2] [3] [4] 31 ]. Lu et al. [2] reported that they sequenced SARS-COV-2 genomes from nine individuals from the same location and found that they had 99.98 sequence identity. However, analysis of the sequences of SARS-CoV-2 isolated in different populations and environments must be made to determine differences in infectivity and virulence that are populations and environments specific. Analysis of mutations in SARS-CoV-2 encoded proteins from SARS-CoV-2 strains/sub-strains isolated from various populations and regions have been reported [10] [11] [12] [13] [14] . It is anticipated that the consequences of identified mutations will be studied as they may explain how SARS-CoV-2 encoded proteins interact with cellular [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . It is significant that mutations take place within a stretch that is phosphorylation rich and forms a phosphorylation dependent binding site for protein 14-3-3 [54, 55] , an important signaling molecule that is involved in the control of the cell cycle, cell survival and cell death [26] [27] [28] [29] [30] . Of particular interest is phospho-serines 197 and 206 which are C-TAK1 phosphorylation sites recognized by protein 14-3-3. Mutations of the phosphorylation sites described in this paper would result in the inability of protein 14-3-3 to bind to the SARS-CoV-2 nucleocapsid protein, the consequence of which would be its unfettered actions, including its ability to J o u r n a l P r e -p r o o f dimerize, bind to the SARS-COV-2 genome, control and up-regulate the replication, transcription and packaging of the SARS-CoV-2 genome [15, 16] . Surijit et al. [74] have described the role of protein 14-3-3 in the translocation of SARS-CoV-2 nucleocapsid protein from the nucleus to the cytoplasm. In this work, structural analysis of SARS-CoV-2 nucleocapsid protein and protein 14-3-3 shows that only monomeric SARS-CoV-2 nucleocapsid protein can form a complex with protein 14-3-3. Here, we propose that in response to SARS-CoV-2 infection, cellular protein 14-3-3 acts to prevent the dimerization of SARS-CoV-2 nucleocapsid protein, replication, transcription and packaging of the SARS-CoV-2 genome. Protein 14-3-3 achieves this by binding to SARS-CoV-2 Nucleocapsid protein and sequestrating it in a phosphorylation dependent manner following phosphorylation of SARS-CoV-2 nucleocapsid protein by several protein kinases that control the cell cycle, including C-TAK1 and possibly CKI, Cdk1, Cdk-5, GSK-3 (Manuscript in preparation). It is also proposed that the phosphorylation of SARS-CoV-2 nucleocapsid protein and its sequestration by protein 14-3-3 is a cellular response mechanism for the control and inhibition of the replication, transcription and packaging of the SARS-CoV-2 genome. A novel coronavirus from patients with pneumonia in China Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding A pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human J o u r n a l P r e -p r o o f respiratory diseaase in China SARS-COV-2 infection and virulence: reverse correlations with temperature, humidity and far infrared radiation. Elevated temperature, humidity and far infrared irradiation will significantly lower the viability, infectivity and virulence of SARS-COV-2 SARS-COV-2 Infection and Virulence: Comparison between United Kingdom and Germany, and other European countries RBD mutations from circulating SARS-CoV-2 strains enhance the structure stability and infectivity of the spike proteins. bioRxiv Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant Genetic diversity and evolution of SARS-CoV-2 Mutated COVID-19 may foretell a great risk for mankind in the future Genotyping coronavirus SARS-CoV-2: methods and implications Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission The SARS coronavirus nucleocapsid protein--forms and functions Immunological characterization of the nucleocapsid protein based SARS vaccine Prediction and analysis of key protein structures of 2029-nCoV The Nucleocapsid protein of Severe Acute Respiratory Syndrome-Coronavirus Inhibits the Activity of Cyclin-Cyclindependent Kinase Complex and Blocks S Phase Progression in Mammalian Cells Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells Principles of CDK regulations From cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner Cyclin dependent kinases and cell cycle control Role of protein phosphatase-2A (PP-2A) in the control of mitosis and meiosisNew 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 14-3-3 family members act coordinately to regulate mitotic progression 14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal Facilitates Bad Interaction with Bcl-x(L) during Apoptosis Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field Toward optimal fragment generations for ab initio protein structure assembly The crystal structure of the nonliganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization Presenting your structures: the CCP4mg molecular-graphics software Docking flexible ligands in proteins with a solvent exposure-and distance-dependent dielectric function The FoldX web server: an online force field ZDOCK server: Interactive docking prediction of protein-protein complexes and symmetric multimers Cell cycle-dependent localization of casein kinase I to mitotic spindles Regulation of p53-MDMX interaction by casein kinase 1 alpha Isoform Shows Cell Cycle-specific Localization to Sites of Polarized Growth and Is Required for Proper Septin Organization Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation Regulation of chromosome segregation by Roles of Aurora Kinases in Mitosis and Tumorigenesis Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution Use of an oriented peptide library to determine the optimal substrates of protein kinases Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3 GSK-3: Functional Insights from Analysis of the role of GSK3 in the mitotic checkpoint Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase Consensus Sequences as Substrate Specificity Determinants for Protein Kinases and Protein Phosphatases Purification of a Serine Kinase That Associates with and Phosphorylates Human Cdc25C on Serine 216 Functional analysis of CTAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate The SARS coronavirus nucleocapsid protein--forms and functions Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver A new activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+-, calmodulin-dependent protein kinase. Purification and characterization Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3 monooxygenase in the presence of Ca2+, calmodulin-dependent protein kinase II 14-3-3 proteins: a historic overview Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine The structural basis for 14-3-3:phosphopeptide binding specificity X-Ray Structures of the N-and CTerminal Domains of a Coronavirus Nucleocapsid protein: Implications for Nucleocapsid Formation Crystal structure of SARS-CoV-2 nucleocapsid Crystal structure of the C-terminal domain of SARSCoV-2 nucleocapsid protein Structure of SARS-CoV-2 Nucleocapsid dimerization domain Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2 A. Bracher, 1.45 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2 Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables Coronavisrus transition from discontinuous transcription Glycogen synthase kinase-3 regulates the viral replication between amino acids 180-210)rendering of the structure of SARS-COV-2 Nucleocapsid protein (amino acids 123-309). The structure of SARS-COV-2 Nucleocapsid protein (amino acids 123-309) depicted here was rendered pursuant to Xu and Zhang [33,34]. The phosphorylation rich stretch encompassing amino acids 180 to 210 is shown as spheres in blue and is localized at the surface of SARS-COV-2 Nucleocapsid protein This paper describes for the first time mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein all located within a stretch which forms a phosphorylation dependent interaction site for binding and sequestration by protein It is proposed that the phosphorylation of SARS-CoV-2 nucleocapsid protein by cellular protein kinase, including C-TAK1 and its sequestration by Protein 14-3-3 is a cellular response mechanism for the control and inhibition of the replication, transcription and packaging of the SARS-CoV-2 genome RE: MANUSCRIPT ENTITLED This work was supported by the Nacbraht Biomedical Research Institute Fund. The authors would like to thank the Zhang Lab for the rendering of the structure of SARSCOV-2 Nucleocapsid protein (amino acids 123-310).